News

LATEST NEWS FROM DISHMAN CARBOGEN AMCIS

Below, you will find the latest news from CARBOGEN AMCIS, the Dishman Group and the industry as a whole. Please do not hesitate to contact us if you would like further information on any of the items below.

  • CARBOGEN AMCIS announces major investments of more than CHF 100 million in Switzerland and France

    News

    CARBOGEN AMCIS announces major investments of more than CHF 100 million in Switzerland and France

    BUBENDORF, Switzerland (August 17, 2020) — Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient...

    Read more

  • Dishman Carbogen Amcis Ltd Statement on COVID-19

    News

    Dishman Carbogen Amcis Ltd Statement on COVID-19

    Dear Customers and Partners,

    We at Dishman Carbogen Amcis group of companies are taking the risks associated with COVID-19 very seriously, and have already implemented a set of measures aimed at limiting any risk to our employees, customers...

    Read more

  • ISO22716 Cosmetics GMP standard accreditation

    News

    ISO22716 Cosmetics GMP standard accreditation

    BUBENDORF, Switzerland (May 22nd, 2019) — Switzerland-based CARBOGEN AMCIS AG, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announced today that its Manchester site successfully...

    Read more

  • Dishman Carbogen Amcis Ltd. Announces a Successful FDA Inspection of its Site in Bavla, India

    News

    Dishman Carbogen Amcis Ltd. Announces a Successful FDA Inspection of its Site in Bavla, India

    Ahmedabad, India (November 5th, 2018) — India-based Dishman Carbogen Amcis Ltd, a global outsourcing partner for the pharmaceutical industry, announced today that its manufacturing and...

    Read more

  • DISHMAN CARBOGEN AMCIS OPENS OFFICE IN KYOTO, JAPAN

    News

    Dishman Carbogen Amcis Ltd Opens Office in Kyoto, Japan

    BUBENDORF, Switzerland (August 1st, 2018) — Switzerland-based CARBOGEN AMCIS AG, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announced today the opening of their new...

    Read more

    Company Profile

    CONTACT US TODAY OR DOWNLOAD
    OUR COMPANY PROFILE BROCHURE
    FOR FURTHER INFORMATION

    SUBSCRIBE TO OUR MAILING LIST FOR THE LATEST NEWS UPDATES